|
Podcast: Emerging Checkpoint Inhibitor–Based Strategies for Advanced Endometrial Cancer
This expert-led episode of Oncology Data Advisor TM, presented by leading experts Ritu Salani, MD, Director of the Division of Gynecologic Oncology and Professor of Obstetrics and Gynecology at the University of California, Los Angeles (UCLA), and Floor Backes, MD, Professor of Obstetrics and Gynecology at The Ohio State University College of Medicine.ain expert insight and enhance your clinical knowledge with this case-based activity focusing on the pathology, treatment, and management of adv... |
|
|
Video Viewpoint Strategy Session: Emerging Checkpoint Inhibitor–Based Strategies for Advanced Endometrial Cancer
Gain expert insight and enhance your clinical knowledge with this case-based activity focusing on the pathology, treatment, and management of advanced endometrial cancer, presented by leading experts Ritu Salani, MD, Director of the Division of Gynecologic Oncology and Professor of Obstetrics and Gynecology at the University of California, Los Angeles (UCLA), and Floor Backes, MD, Professor of Obstetrics and Gynecology at The Ohio State University College of Medicine. Start the activity now!
... |
|
|
Podcast: New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia
Discover recent developments in the prevention, treatment, and management of chemotherapy-induced neutropenia, including a comprehensive understanding of the risk factors and current clinical practice guidelines. This activity is presented by Gary H. Lyman, MD, MPH, FASCO, FACP, FRCP, Professor, University of Washington, and Maura Abbott, PhD, AOCNP®, CPNP, Columbia University School of Nursing. Start the activity now.
STATEMENT OF NEED
Chemotherapy-induced neutropenia (CIN) is a potent... |
|
|
Video Viewpoint Strategy Session: New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia
Discover recent developments in the prevention, treatment, and management of chemotherapy-induced neutropenia, including a comprehensive understanding of the risk factors and current clinical practice guidelines. This activity is presented by Gary H. Lyman, MD, MPH, FASCO, FACP, FRCP, Professor, University of Washington, and Maura Abbott, PhD, AOCNP®, CPNP, Columbia University School of Nursing. Start the activity now.
STATEMENT OF NEED
Chemotherapy-induced neutropenia (CIN) is a potent... |
|
|
Video Viewpoint Strategy Session: Harnessing Immunotherapy-Based Strategies for Advanced Non–Small Cell Lung Cancer
This expert-led discussion, presented by Ticiana Leal, MD, Director of the Thoracic Medical Oncology Program at Winship Cancer Institute of Emory University, and Beth Sandy, MSN, CRNP, Thoracic Oncology Nurse Practitioner at Abramson Cancer Center of University of Pennsylvania, will focus on emerging efficacy and safety data on immunotherapy-based strategies, supportive care plans for adverse events, and optimizing care plans for the survivorship of patients with non–small cell lung cancer. ... |
|
Newborn Screening: Talking to Parents
This is the second module in a four-part curriculum focused on Best Practices for Explaining Newborn Screening Results to Parents. This module will focus on how to talk to parents about positive NBS results. |
|
|
Newborn Screening: Metabolic Conditions
This is the third module in a four-part curriculum focused on Best Practices for Explaining Newborn Screening Results to Parents. This module will focus on metabolic diseases which are part of the Recommended Uniform Screening Panel (RUSP) in order to better prepare clinicians to discuss positive results with new parents. |
|
|
Newborn Screening: Hemoglobinopathies and Newer Disorders on the RUSP
This is the fourth module in a four-part curriculum focused on Best Practices for Explaining Newborn Screening Results to Parents. This module will focus on hemoglobinopathies and newer disorders which are part of the Recommended Uniform Screening Panel (RUSP) in order to better prepare clinicians to discuss positive results with new parents. |
|
|
Newborn Screening: From RUSP to Reality
This is the first module in a four-part curriculum focused on Best Practices for Explaining Newborn Screening Results to Parents. This module will provide clinicians with the fundamentals of newborn screening. |
|
Infusing Renewed Hope into Cancer-related Anemia with Intravenous Iron: AN EXPERT-LED EXPLORATION OF RECENT AND EMERGING TRIAL DATA AND CURRENT GUIDELINE RECOMMENDATIONS
Designed and developed to maximize digital audience reach and engagement, this Medical Moments webinar will review all clinically relevant aspects of cancer-related anemia (CRA) management, including chemotherapy-induced anemia (CIA). The activity will begin with a brief primer on iron metabolism and absorption principles, including the practical distinctions between absolute and functional iron deficiency, and the impact of that distinction on treatment approaches. An appraisal of the foundat... |
|
|
New Insights and Avenues for Improved Patient Outcomes in Immune Thrombocytopenia
Gain expert insight on new treatment approaches to improve outcomes for patients with immune thrombocytopenia, including individualized treatment for patients who relapse and strategies to alleviate and improve supportive care. This discussion is led by Howard Liebman, MD, Professor of Medicine and Pathology at the University of Southern California Keck School of Medicine, and Allison Miller lmahiyerobo, MSN, APN, Advanced Practice Nurse at Hematology and Oncology Physicians of Englewood. Star... |
|
Paths to Functional Recovery in Major Depressive Disorder: Putting the Patient First A Patient-Centered Approach to Preventing, Detecting, and Managing Adverse Effects of Antidepressants
Adverse effects associated with antidepressants are common. In addition to compromising patients’ health and quality of life, they are one of the most common reasons that individuals with MDD fail to adhere to their treatment plans. To minimize the impact of antidepressant side effects on the lives of patients with MDD, clinicians require education on how to prevent, detect, and manage the most common adverse effects caused by these medications. In this activity, an expert faculty member wil... |
|
|
Paths to Functional Recovery in Major Depressive Disorder: Putting the Patient First Combining Patient-Centered Care for MDD with the Latest Antidepressant Efficacy to Optimize Treatment Plans
Only roughly half of patients with MDD achieve recovery after 6 months of treatment. The others continue to experience residual symptoms that impair their ability to function at work, school, and home. To ensure that more patients with MDD achieve functional recovery, clinicians require practical information about how to provide early, optimized care. In this activity, an expert faculty member will support learners as they are asked to track patients’ response to treatment and detect and man... |
|
|
Implementing the APA Guidelines for the Treatment of Schizophrenia: Caring for the Whole Person
In fall 2020, the American Psychiatric Association (APA) released new practice guidelines for the treatment of patients with schizophrenia. The new guidelines were eagerly awaited, because in the 16 years since the last update, many important discoveries about schizophrenia had been made. An overarching theme in the new APA guidelines is person-centered care. This approach is critical for improving outcomes; currently, as few as 14% to 50% of patients with schizophrenia achieve recovery. Howe... |
|
|
Updates in Myelodysplastic Syndromes: Improving Patient Outcomes
This activity, presented by Mikkael Sekeres, MD, Chief of the Division of Hematology at the University of Miami Health System, will focus on predictive and prognostic markers for myelodysplastic syndromes (MDS), emerging data on novel therapies, and strategies to optimize safety and tolerability for patients with this disease. Start the activity now.
STATEMENT OF NEED
Myelodysplastic syndromes (MDS) comprise a heterogeneous group ofmyeloid malignanciesthat derive from abnormal multipot... |
|
|
Improving Outcomes in Hodgkin Lymphoma
This in-depth discussion, presented by Louis Diehl, MD, Professor of Medicine at Duke University Medical School, will feature strategies for incorporating predictive and prognostic markers, recent efficacy and safety data, and adverse event management strategies into treatment selection for patients with Hodgkin lymphoma (HL). Start the activity now.
STATEMENT OF NEED
Hodgkin lymphoma (HL) is a rare malignancy of the lymph nodes and lymphatic system, with about 8,830 new cases diagnosed ... |
|
|
Therapy of B-Cell Acute Lymphoblastic Leukemia: An Evolving Landscape
Presented by Amir Fathi, MD, Associate Professor of Medicine at Harvard Medical School, this activity will highlight individualized treatment selection for patients with acute lymphoblastic leukemia (ALL), as well as recent efficacy and safety data for novel therapeutic strategies. Start the activity now.
STATEMENT OF NEED
Acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the proliferation of immature lymphoid cells throughout the bone marrow and blood (Rana... |
|
|
Podcast: Optimizing Management of Metastatic Squamous Non-Small Cell Lung Cancer
Discover new developments in the management of metastatic squamous non–small cell lung cancer (NSCLC), including individualized care plans, efficacy and safety of novel therapies, and strategies to optimize survivorship for patients with NSCLC. This activity is presented by expert faculty, Mark G. Kris, MD, Memorial Sloan Kettering Cancer Center, and Victoria Sherry, DNP, CRNP, AOCNP®, Nurse Practitioner, Abramson Cancer Center. Start the activity now.
STATEMENT OF NEED
Squamous ce... |
|
|
Video Viewpoint Strategy Session: Optimizing Management of Metastatic Squamous Non-Small Cell Lung Cancer
Discover new developments in the management of metastatic squamous non–small cell lung cancer (NSCLC), including individualized care plans, efficacy and safety of novel therapies, and strategies to optimize survivorship for patients with NSCLC. This activity is presented by expert faculty, Mark G. Kris, MD, Memorial Sloan Kettering Cancer Center, and Victoria Sherry, DNP, CRNP, AOCNP®, Nurse Practitioner, Abramson Cancer Center. Start the activity now.
STATEMENT OF NEED
Squamous ce... |
|
|
Expert Perspectives on Practice-Changing Strategies for Improved Patient Outcomes in Multiple Myeloma - Part 2
STATEMENT OF NEED
Multiple myeloma is a B-cell neoplasm characterized by expansion of plasma cells within the bone marrow and extramedullary sites (ACS, 2021). For patients who relapse, treatment becomes increasingly complex, and outcomes worsen with each relapse (Siegal et al, 2020). Advanced multiple myeloma may be associated with considerable disease-related comorbidities in addition to treatment-related adverse events and impaired quality of life, all of which increase the challenges of... |
|
|
Expert Perspectives on Practice-Changing Strategies for Improved Patient Outcomes in Multiple Myeloma - Part 1
STATEMENT OF NEED
Multiple myeloma is a B-cell neoplasm that occurs primarily in older adults. The incidence is expected to rise in conjunction with the aging population. Because symptoms often do not appear until the malignancy is in advanced stages, early diagnosis is difficult, and the 5-year relative survival rate remains only 54% (ACS, 2021). Following diagnosis, management must be guided by cytogenic markers with prognostic significance and correct staging based upon these markers (NC... |
|
Understanding and Managing Nontuberculous Mycobacteria-Lung Disease
This educational module focuses on nontuberculous mycobacterial (NTM) lung disease, its diagnosis, treatment, and patient management. An expert panel discussion, animations, and a patient’s story are highlighted within this education. This EXPLORE module has highly interactive and engaging online content, designed to allow learners to choose their own learning course. |
|
|
New Data and Emerging Management Strategies for Migraine Headache
STATEMENT OF NEED
Migraine is a type of chronic headache disorder characterized by headaches of a stabbing, pulsatile quality that last between 4 and 72 hours each, often accompanied by symptoms of nausea and sensitivity to light and noise. An estimated 1.04 billion individuals have been diagnosed with migraine worldwide (Negro et al, 2019). Patients report that migraine impacts virtually every aspect of their lives, including personal relationships, reproductive choices, and productivity i... |
|
|
Applying Precision Medicine in BRAF V600E–Mutant Metastatic Colorectal Cancer
STATEMENT OF NEED
Colorectal cancer is the second leading cause of cancer death among men and women in the United States (ACS,2021). An estimated 149,500 new cases are diagnosed annually, and 52,980 people die of the disease (ACS, 2021). When detected and treated early at a localized stage, the 5-year survival rate is 90%. However, because colorectal cancer initially exhibits no symptoms and the use of routine screening is suboptimal, most patients are diagnosed at later stages (ACS, 2021).... |
|
|
Video Viewpoint Strategy Session: Optimizing Treatment and Functional Outcomes in Head and Neck Squamous Cell Carcinoma
Gain expert insight on emerging treatment approaches for patients with head and neck squamous cell carcinoma, incuding the safety and tolerabilty of emerging treatments, survivorship care, and much more. This activity is presented by leading experts, Barbara Burtness, MD, Professor of Medicine at Yale School of Medicine and Smilow Cancer Hospital, and Lynsey Teulings, NP, Nurse Practitioner at Yale School of Medicine and Smilow Cancer Hospital. Start the activity now.
STATEMENT OF NEED
H... |
|
|
Best Practices in the Management of Tumor Lysis Syndrome Associated With Emerging Cancer Therapies
Explore best practices in the management of tumor lysis syndrome associated with emerging cancer therapies. This activity, presented by Matthew S. Davids, MD, MMSc, Director of Clinical Research at Dana-Farber Cancer Institute, and Amy Goodrich, RN, BSN, MSN, CRNP-AC, Nurse Practitioner at Johns Hopkins Kimmel Cancer Center, will review plans to optimize prevention, recognition, and treatment, as well as discuss emerging therapies and monitoring strategies for patient care. Start the activity ... |
|
|
Podcast: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer
In this episode of Oncology Data Advisor TM, learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and Jennifer Filipi, MSN, FNP-C, Massachusetts General Hospital. Listen now!
STATEMENT OF NEED
Th... |
|
|
Video Viewpoint Strategy Session: Update on Immunotherapeutic Strategies for Recurrent and Metastatic Cervical Cancer
Learn more about emerging immunotherapies for the treatment of recurrent and metastatic cervical cancer, strategies to monitor and manage adverse events, and developments in the standard of care for patients wth cervical cancer. This activity is presented by leading experts, Bradley Monk, MD, FACS, FACOG, University of Arizona College of Medicine, and Jennifer Filipi, MSN, FNP-C, Massachusetts General Hospital. Start the activity now!
STATEMENT OF NEED
There are an estimated 13,800 new c... |
|
|
Addressing Challenges in Diagnosis and Treatment of Low-Grade Upper Tract Urothelial Carcinoma
OVERVIEW
Upper tract urothelial carcinoma (UTUC) has many similarities to bladder carcinoma, but also some important differences. Join Dr. Seth Lerner, as he contrasts these 2 diseases, as well as important differences between low-grade and high-grade UTUC. Dr. Lerner highlights important considerations in the instruments, imaging, and biopsy techniques for diagnosing low-grade UTUC. Surgical options are considered, with a focus on patient selection for endoscopic nephron-sparing surgery. The... |
|
|
Clinical Diversity and Genetic Variation in Lysosomal Disorders
Explain the principles of Pathogenic Processes in LSDs.
Explain that lysosomal composition, shape, contents, numbers differ between cell types
and have an effect on disease expression.
Review the evolving understanding of lysosomal autophagy functions. |
|
|
Video ViewPoint Strategy Session: Rethinking the Management of Differentiated and Anaplastic Thyroid Cancers
Gain expert insight and strategies for the management of anaplastic thyroid cancer including emerging data on immunotherapies, and treatment to manage adverse events. This activity is presented by leading experts, Jochen Lorch, MD, MSc, Director Thyroid Cancer Center, Dana-Farber Cancer Institute, and Carolyn Grande, CRNP, AOCNP®, Oncology Nurse Practitioner, Abramson Cancer Center.
STATEMENT OF NEED
Thyroid cancer is one of the most prevalent cancers in the United States. An estimated ... |
|
|
Metastatic Triple-Negative Breast Cancer: Applying Treatment Advances to Personalized Care
Sara A. Hurvitz, MD, FACP, Director of the Breast Cancer Clinical Trials Program at the David Geffen School of Medicine at UCLA, and a prominent authority on TNBC, provides perspectives on personalized care plans for patients with metastatic TNBC, efficacy and safety of emerging treatments, strategies to improve quality of life for patients with metastatic TNBC, and much more! Start the activity now!
STATEMENT OF NEED
With an estimated 284,200 new cases per year, breast cancer is the mo... |
|
|
Two Pediatric Bone Disorders in the Era of Disease Specific Therapies – When to Refer Patients and How to Treat XLH and HPP
Target Audience
This activity is designed to meet the educational needs of pediatricians in endocrinology, primary care, rheumatology, orthopedics, neurology, radiology, nephrology, neonatology, and other speciaties. Healthcare providers including geneticists and genetic counselors are included.
Program Overview
X-linked hypophosphatemia (XLH) and hypophosphotasia (HPP) are genetic metabolic bone diseases with recent treatment advances. This program will discuss when to refer and how ... |
|
|
Management of Large B-Cell Lymphomas: A Critical Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma and CAR T-Cell Therapy
TARGET AUDIENCE:
Hematologist-oncologists, pathologists, histologists, advanced practitioners, oncology nurses, pharmacists, and other healthcare professionals involved in the care of patients diagnosed with LBCL.
PROGRAM OVERVIEW:
In this activity, Jeremy Abramson, MD, highlights the significant disease burden of B-cell lymphomas, as well as the latest advances in therapeutics, and practical strategies for integrating novel therapies into practice through patient selection and supportive c... |
|
|
Cruising the Seychelles & Coastal Tanzania: Hot Topics in Medical, Dental & Public Health Issues
Luxury Expedition with Abercrombie & Kent on Le Jacques Cartier
March 11 – 24, 2023
Join PES on an unforgettable, luxury expedition cruise aboard the 148-guest Le Jacques Cartier with A&K’s renowned Expedition Team for 12 nights exploring coastal Tanzania and Seychelles, where idyllic beaches, lush emerald mountains, and UNESCO-protected wildlife reserves await!
CME/CE Lecture Seminars for Medical, Dental, Nursing and Allied Healthcare Professionals
This Seminar is planned for 14... |
|
|
Stage IV Melanoma: Strategies to Support Shared Decision Making
Target Audience
This activity is intended for oncology care providers (including physicians, advanced practice providers, nurses, and other HCPs) who care for patients with melanoma.
Program Overview
The explosion of therapeutic options for Stage IV disease has heralded improved outcomes for patients with Stage IV melanoma. However, this expanded array of available options brings increased complexity for decision making. This activity, Stage IV Melanoma: Strategies to Support Shared D... |
|
|
Principles of Medical Education: Maximizing Your Teaching Skills - LIVE STREAMING
The Techniques and Strategies that Significantly Improve Student Engagement and Teaching and Mentoring Effectiveness
Principles of Medical Education: Maximizing Your Teaching Skills will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.
OVERVIEW
Incorporating best practices, newer principles of adult learning, and widely available technologies into your teaching can significantly improve your ability to engage and inspire students, ... |
|
|
Optimizing Treatment in the Underdiagnosed Eosinophilic Esophagitis (EoE): An Interactive Guide
TARGET AUDIENCE:
This activity was developed for gastroenterologists, allergists, immunologists, pediatric gastroenterologists, pediatric allergists/immunologists, specialty NP/PAs, and other healthcare professionals who have an interest in Eosinophilic Esophagitis.
PROGRAM OVERVIEW:
Ikuo Hirano, MD, provides his academic expertise in esophageal swallowing physiology and clinical experience to improve the management of patients with eosinophilic esophagitis (EoE). To distinguish EoE from a ... |
|
|
6th Edition of Nursing World Conference (Hybrid Event)
Magnus Group is glad to have this opportunity to invite one and all to its timely conference “6th Edition of Nursing World Conference” (NWC 2022) which will be held as a hybrid event at Orlando, Florida, USA and virtually from October 27-29, 2022.
The congress runs on its unique theme “Pioneering Spirit of Enriching the Nursing Profession.”
This global summit provides a wonderful opportunity for all nursing professionals to learn about current trends in nursing practise around th... |
|
|
Community Practice Connections™: Determining When and How to Integrate PCSK9 Inhibition Into Practice
Target Audience
This educational activity is directed toward internists and internal medicine subspecialists. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in lipid management will be invited to participate, as well.
Program Overview
Proprotein convertase subtilisin/kexin type 9 (PCSK9) serine protease inhibitors provide important advances in the management of dyslipidemia and cardiovascular disease risk. Clinician education about curr... |
|
|
Next Generation Pneumococcal Vaccines: What You Need to Know
What’s new with pneumococcal vaccines? In 2021, two exciting, next-generation pneumococcal vaccines have become available. Expert faculty from Loma Linda University, the University of Pittsburgh School of Medicine, and the Lewis Katz School of Medicine at Temple University recently led a symposium at a major internal medicine meeting outlining the characteristics and latest recommendations with these novel vaccines. Learn how to overcome present barriers with vaccine uptake (particularly ami... |
|
|
LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery (Patient Whiteboard)
LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery (Patient Whiteboard) is a brief whiteboard animation developed to provide patients with the right information to achieve full functional recovery and find your light again.
Learn strategies on:
• the signs, symptoms, and causes of emotional blunting
• how to recognize when your treatment is not right for you
• the importance of active communication with your healthcare pro... |
|
|
LET'S BE BLUNT: Collaborating With Patients With Major Depressive Disorder to Achieve Full Functional Recovery
In this, 60-minute activity, expert faculty review recommendations for the treatment of major depressive disorder (MDD), case vignettes, and “How I Do It” best practices. Discussions focus on the impact of measurement-based care for tracking symptoms of depression; assessment and management of treatment-related emotional blunting; as well as, strategies on how to involve patients in shared decision making. Join this activity and help your patients find the light again. |
|
|
Expert Insights: Precision Medicine in Non-Small Cell Lung Cancer
Target Audience
This activity is designed to meet the educational needs of advanced practitioners (NP/PA), and other healthcare professionals involved in the care of patients with NSCLC.
Program Overview
This activity will highlight the most clinically relevant data presented during an independent satellite symposium in conjunction with the 2022 Oncology Nursing Society’s (ONS) Annual Conference and its potential impact on current and future strategies for managing patients with Non... |
|
|
Community Practice Connections™: Venous Thromboembolism: Patient-Centric and Guideline-Directed Strategies for Optimal Coordinated Care
Target Audience
The target audience for this activity is internists and internal medicine subspecialists. Other primary care providers, nurse practitioners, physician assistants, nurses, and other health care professionals involved in VTE management are invited to participate as well.
Program Overview
Venous thromboembolism (VTE) is a serious and underdiagnosed medical condition that manifests as deep vein thrombosis (DVT) and/or pulmonary embolism (PE) and can cause serious illness, ... |
|
|
Community Practice Connections™: Anemia of Chronic Kidney Disease – Understanding the Disease to Improve Patient Outcomes
Target Audience
This educational activity is directed toward internists and other internal medicine specialists. Nurse practitioners, physician assistants, nurses, and other health care professionals involved in CKD anemia management will be invited to participate as well.
Activity Overview
Anemia in patients with chronic kidney disease (CKD) can result in reduced quality of life, increased risk of cardiovascular problems, and even death. Optimal care for these patients includes suppo... |
|
|
Advances In™ Personalizing MS Management Plans: Strategies for Optimizing Long-Term Patient Outcomes in MS and Individualizing Treatment within the S1P Receptor Modulator Class
Target Audience
This educational activity is directed toward neurologists and other health care providers who care for patients with MS.
Program Overview
This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of multiple sclerosis (MS) with a forward-looking perspective on how new and novel agents might impact clinical practice. The integration of biomarkers into diagnosis, efficacy of various disease-modifying therapies... |
|
|
First Do No Harm: Strategies for Managing Non-Cancer Pain in Your Clinic
Target Audience
This activity is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professions caring for patients with pain.
Program Overview
This activity will help you apply the fundamentals of pain management – assessment, treatment, and management of patient with pain – both acute and chronic. Following 2 patient cases, this 4-part, short form, video-based activity, will provide strategie... |
|
|
3rd Edition of Singapore Nursing Research Conference
Given the huge success of the previous conferences and the strong interest in Nursing 2022, we look forward to welcoming you at our “3rd Edition of Singapore Nursing Research Conference” scheduled during March 16-18, 2023 at Singapore.
Considering the current unprecedented challenges, we have chosen a hybrid format with on-site as well as online editions for this conference.
The congress will be centred around the theme “Exploring Challenges in Nursing Research: The Unsung Frontline Wa... |
|
|
Career Advancement and Leadership Skills for Women in Healthcare - LIVE STREAM
Strategies and Skills Development for Career Advancement and Leadership
This professional development program, which is among the highest-rated Harvard Medical School CME courses, delivers evidence-based strategies, skills development and education that help women at various stages of their healthcare careers step into and succeed in leadership positions. It also helps to effectively cultivate highly qualified current and future women leaders by developing the following competencies:
CARE... |
|